3SOF

BDY
       Good company,Trailing P/E (ttm, intraday): 59.78
                             Forward P/E (fye 31-Dec-06) 1: 11.96
                             Revenue (ttm): 123.66M
                             Revenue Per Share (ttm): 7.761
                             Qtrly Revenue Growth (yoy): 49.50%
                             Gross Profit (ttm): 83.35M
                             EBITDA (ttm): 21.97M
                             Net Income Avl to Common (ttm): 3.10M
                             Diluted EPS (ttm): 0.23
                             Qtrly Earnings Growth (yoy): 119.20%

Have not bought yet.For me the buy criteria at this point is vol. to be close to 250000 and price crossing 14.02.

BDY still a valid trade.had the vol. but the price did not make it to 14.02.
Also will be looking at,
SCLN
  Price above 2.9 Vol around 700000


SciClone Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics to treat life-threatening diseases. Its products include ZADAXIN is in phase 3 hepatitis C virus clinical trials, as well as in other late-stage clinical trials for the treatment of hepatitis B virus and certain cancers. The company also develops SCV-07, which is in preclinical studies, for the treatment of viral and other infectious diseases. The company sells its products primarily in Asia, the Middle East, and Latin America. SciClone Pharmaceuticals was founded in 1989 and is headquartered in San Mateo, California.
has cash to R&D
Total Cash (mrq): 41.56M
Total Cash Per Share (mrq): 0.906
Total Debt (mrq): 1.60M
Total Debt/Equity (mrq): 0.031
Current Ratio (mrq): 6.758
Book Value Per Share (mrq): 1.113
Once it crosses over 2.9 it has enough room to grow to about 3.53.

Scln price hit and volume is way high in the am trading.Bought at 2.92
BDY still looking good will hit the vol. don't know about the price yet.

I will drop Bdy from my radr for now.
Scln from 2.92-3.08 approx 5.47% gain will still hold.
CIPH looking good/Good vol.spike today.

Ciphergen Biosystems, Inc. engages in the development, manufacture, and marketing of a family of ProteinChip Systems and services for clinical, research, and process proteomics applications for life science researchers
Good looking chart couple of resistance at 2.25 and 2.29
All the moving averages have lined up right 5 over 13,13 over 20 and 20 over 50.Great crossover

Ciph in at 2.11
scln dropped .04 to close at 3.04 but still looking good.

Monday will be looking at EMIS.
Loss narrows.
Money coming in  3 month mov. avg.=186766 10 day avg. vol=217033 vol. FRI.=541743
Industry drug delivery system which is improving.

Nice news on  SCLN this morning. Chart looks like it has room to run to 4, but I'll be waiting for a dip to get in. Could be a run away gap up, if so I'll stay on sidelines.

I do not think you will see a dip till around 4.

EMIS volume is drying out still watching.I would like to see vol on track to 400000+

Will still be looking at EMIS but volume has to come back.One more pick I will be watching tommorrow WTSLA.vol. is picking up.Wet seal inc.will have their earnings out on the 23rd.They are expected to earn .03.
In January 2005 we initiated the primary component of our turnaround strategy, our new merchandise approach for our Wet Seal brand. This approach, among other things, consisted of lower retail prices, a broader assortment of fashion-right merchandise and more frequent delivery of fresh merchandise. Since the introduction of this new strategy, we have experienced comparable store sales growth of 29.8%, 55.9% and 46.6% for the fiscal quarters ended April 30, 2005, July 30, 2005 and October 29, 2005, respectively. The recent comparable store sales trend has resulted entirely from increased transaction counts. The acceleration of comparable store sales results continues to validate our merchandise strategy for our Wet Seal business. As a result of our improving sales trend and the completion of our Wet Seal division store closure plan, we experienced a significant improvement in our net loss from continuing operations for the 13-week and 39-week periods ended October 29, 2005 versus the same periods a year ago. Gross margin expanded to 30.8% and 31.7% of sales, respectively, for the 13-week and 39-week periods ended October 29, 2005, versus 16.5% and 13.7%, respectively, for the comparable periods a year ago, driven by the improving sales in existing stores, lower merchandise markdowns and the benefits of closing low volume stores. Our current operating performance trend and recent financing transactions have resulted in increased liquidity for the Company and, in turn, improved our current credit standing with suppliers, which may further improve our liquidity. However, we cannot assure you that we will not experience future declines in comparable store sales. If our current sales trends do not continue and our comparable store sales drop significantly, this could impact our operating cash flow and we may be forced to seek alternatives to address our cash constraints, including seeking additional debt and/or equity financing

This was the forward looking statement from last qtr.Last line talks about posible cash constraints if certain criterias are not met.Yet cash shown on yahoo balance sheet for the company is 70.23.If I do buy it tommorrow I will have to keep the trigger hot.

EMIS is done for now.Doesn't look like we are going to see the vol.coming back today.
WTSLA , vol. at this point is inline to hit a million+.I will buy if it breaks 5.85.Also looking at TMTA,got interested in it after looking at the post on the board.Intraday 1min. chart seems to be making a good double bottom.Intersting if it crosses 2.13.

will be holding SCLN and CIPH,
Will still be looking at WTSLA and adding ENG to the watchlist

Eng missed their earnings.

bought wtsla here at 5.63.AS it crosses it's res. at 5.63.